(Thio)nicotinamide ribofuranoside salts and compositions, methods of making, and uses thereof
AssigneeRoche Diagnostics Operations, Inc.
InventorsUrs Spitz, Günter Schabert, Aysel Soydemir, Lukas Wick
Life of this patent
Estimating the term…
Abstract
The present invention relates to crystalline (thio)nicotinamide ribofuranoside salts, methods of making such crystalline salts, a pharmaceutical composition comprising same, and use of said crystalline salts as nutritional (dietary) supplements. Furthermore, the present invention relates to a composition comprising amorphous (thio)nicotinamide ribofuranoside salts and its use as nutritional (dietary) supplement.
Claims9
A method of making crystalline nicotinamide-β-D-ribofuranoside bromide of formula O-Ia
- or crystalline thionicotinamide-β-D-ribofuranoside bromide of formula S-Ia
- comprising at least step (A):
- (A) subjecting a tetra-O-acyl-β-D-ribofuranose of formula II
- wherein each R is independently selected from acyl, to hydrogen bromide in acetic acid to yield a tri-O-acyl-β-D-ribofuranoside bromide of formula III
- and step (B):
- (B) reacting the compound of formula III with nicotinamide of formula O—IV
- to obtain a nicotinamide-2,3,5-tri-O-acyl-β-D-ribofuranoside bromide of formula O-Va:
- or reacting the compound of formula III with thionicotinamide of formula S—IV
- to obtain a thionicotinamide-2,3,5-tri-O-acyl-β-D-ribofuranoside bromide of formula S-Va:
- wherein the compound of formula O—IV or S—IV is in the form of its salt with acetic acid.
A method of making crystalline nicotinamide-β-D-ribofuranoside bromide of formula O-Ia
- or crystalline thionicotinamide-β-D-ribofuranoside bromide of formula S-Ia
- comprising at least step (A):
- (A) subjecting a tetra-O-acyl-β-D-ribofuranose of formula II
- wherein each R is independently selected from acyl, to hydrogen bromide in acetic acid to yield a tri-O-acyl-β-D-ribofuranoside bromide of formula III
- and step (B):
- (B) reacting the compound of formula III with nicotinamide of formula O—IV
- to obtain a nicotinamide-2,3,5-tri-O-acyl-β-D-ribofuranoside bromide of formula O-Va:
- or reacting the compound of formula III with thionicotinamide of formula S—IV
- to obtain a thionicotinamide-2,3,5-tri-O-acyl-β-D-ribofuranoside bromide of formula S-Va:
- wherein in step (B) the compound of formula O—IV or formula S—IV is used in an excess compared to the compound of formula III.
A method of making crystalline nicotinamide-β-D-ribofuranoside bromide of formula O-Ia
- or crystalline thionicotinamide-β-D-ribofuranoside bromide of formula S-Ia
- comprising at least step (A):
- (A) subjecting a tetra-O-acyl-β-D-ribofuranose of formula II
- wherein each R is independently selected from acyl, to hydrogen bromide in acetic acid to yield a tri-O-acyl-β-D-ribofuranoside bromide of formula III
- and step (B):
- (B) reacting the compound of formula III with nicotinamide of formula O—IV
- to obtain a nicotinamide-2,3,5-tri-O-acyl-β-D-ribofuranoside bromide of formula O-Va:
- or reacting the compound of formula III with thionicotinamide of formula S—IV
- to obtain a thionicotinamide-2,3,5-tri-O-acyl-β-D-ribofuranoside bromide of formula S-Va:
- wherein step (B) is carried out by adding nicotinamide of formula O—IV dissolved in acetonitrile or thionicotinamide of formula S—IV dissolved in acetonitrile to a solution comprising the compound of formula III and acetonitrile, hydrogen bromide and acetic acid, and
- wherein the temperature of the nicotinamide of formula O—IV in acetonitrile or the thionicotinamide of formula S—IV in acetonitrile is kept in a range of from 50° C. to 75° C. and the temperature of the solution comprising the compound of formula III is kept in a temperature range of from −10° C. to 30° C.
A method of making crystalline nicotinamide-β-D-ribofuranoside bromide of formula O-Ia
- or crystalline thionicotinamide-β-D-ribofuranoside bromide of formula S-Ia
- comprising at least step (A):
- (A) subjecting a tetra-O-acyl-β-D-ribofuranose of formula II
- wherein each R is independently selected from acyl, to hydrogen bromide in acetic acid to yield a tri-O-acyl-β-D-ribofuranoside bromide of formula III
- step (B):
- (B) reacting the compound of formula III with nicotinamide of formula O—IV
- to obtain a nicotinamide-2,3,5-tri-O-acyl-β-D-ribofuranoside bromide of formula O-Va:
- or reacting the compound of formula III with thionicotinamide of formula S—IV
- to obtain a thionicotinamide-2,3,5-tri-O-acyl-β-D-ribofuranoside bromide of formula S-Va:
- step (C):
- (C) purifying the compound of formula O-Va or the compound of formula S-Va obtained in step (B), optionally by crystallization, re-crystallization, or crystallization and re-crystallization,
- step (D):
- (D) deprotecting the compound of formula O-Va or formula S-Va obtained in step (B) or step (C) by removing the R groups using hydrogen bromide in acetic acid to give the compound of formula O-Ia or formula S-Ia;
- and step (E):
- (E) purifying the compound of formula O-Ia or formula S-Ia obtained in step (D) by crystallization, re-crystallization, or crystallization and re-crystallization.
Dependencies are inferred from the claim text.